Role of CD4+ and CD8+ T cells in the rejection of concordant pancreas xenografts

Transplantation

Volumn 74, Issue 9, 2002, Pages 1236-1241

  Yin, Deng Ping ^a,b   Ma, Lian Li ^b   Sankary, Howard N ^b   Shen, Jikun ^b   Zeng, Huasong ^b   Varghese, Anncy ^b   Chong, Anita S ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GLUCOSE; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD8; OKT 4; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RAT; RAT STRAIN; SPLEEN CELL; STREPTOZOCIN DIABETES; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TISSUE NECROSIS; XENOGRAFT;

EID: 0037112934     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200211150-00007     Document Type: Article

References (33)

1. Platt JL. The immunological barriers to xenotransplantation. Crit Rev Immunol 1996; 16: 331.
2. Kaufman CL, Gaines BA, Ildstad ST. Xenotransplantation. Annu Rev Immunol 1995; 13: 339.
3. Calne RY, Davis DR, Pena JR, et al. Hepatic allografts and xenografts in primates. Lancet 1970; 1: 103.
4. Tector AJ, Fridell JA, Ruiz P, et al. Experimental discordant hepatic xenotransplantation in the recipient with liver failure: Implications for clinical bridging trials. J Am Coll Surg 2000; 191: 54.
5. Groth CG, Korsgren O, Tibell A, et al. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994; 344: 1402.
6. McKenzie IF, Koulmanda M, Mandel TE, et al. Pig islet xenografts are susceptible to "anti-pig" but not Gala(1, 3)Gal antibody plus complement in Gal o/o mice. J Immunol 1998; 161: 5116.
7. Yin DP, Sankary HN, Ma LL, et al. Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection. Transplantation 2001; 71: 1385.
8. Murphy B, Auchincloss H Jr, Carpenter CB, et al. T cell recognition of xeno-MHC peptides during concordant xenograft rejection. Transplantation 1996; 61: 1133.
9. + T cells. J Exp Med 1989; 170: 991.
10. + indirect response. Xenotransplantation 1998; 5: 93.
11. + T cells and B cells. Transplantation 1996; 61: 1678.
12. + T-cells in rejection of porcine islet cell xenografts. Diabetes 1999; 48: 2340.
13. Mirenda V, Le Mauff B, Boeffard F, et al. Intact pancreatic islet function despite humoral xenorecognition in the pig-to-monkey combination. Transplantation 1998; 66: 1485.
14. Mirenda V, Sigalla J, Fiche M, et al. Pig pancreatic islet xenografts in a B-cell-deficient mouse model. Transplant Proc 1997; 29: 762.
15. + T cell activation and tolerance induction in B cell knockout mice. J Exp Med 1996; 183: 1339.
16. Shizuru J, Taylor-Edwards C, Banks B, et al. Immunotherapy of the nonobese diabetic mouse: Treatment with an antibody to helper lymphocytes. Science 1988; 240: 659.
17. Shizuru J, Gregory A, Chao C, et al. Islet allograft survival after a single course of treatment of recipient with antibody to L3T4. Science 1987; 237: 278.
18. Chen Z, Cobbold S, Metcalfe S, et al. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8. Eur J Immunol 1992; 22: 805.
19. Mottram PL, Murray-Segal LJ, Han W, et al. Long-term survival of segmental pancreas isografts in NOD/Lt mice treated with anti-CD4 and anti-CD8 monoclonal antibodies. Diabetes 1998; 47: 1399.
20. Purcell L, Mottram P. Prevention of both rejection and recurrence of autoimmune disease in the NOD/Lt mouse following segmental pancreas transplantation. Transplant Proc 1995; 27: 2166.
21. Purcell LJ, Mottram PL, Mandel TE. Immunosuppressive antibody treatment prolongs graft survival in two murine models of segmental pancreas transplantation. Immunol Cell Biol 1993; 71: 349.
22. + cells are essential for allorejection. J Exp Med 1996; 184: 2013.
23. Yin D, Fathman CG. CD4-positive suppressor cells block allotransplant rejection. J Immunol 1995; 154: 6339.
24. Yin D, Ma L, Shen J, et al. CTLA-4Ig in combination with anti-CD40L prolongs xenograft survival and inhibits anti-gal Ab production in GT-Ko mice. Am J Transplant 2002; 2: 41.
25. Shen J, Short J, Blinder L, et al. Quantitation of the changes in splenic architecture during the rejection of cardiac allografts or xenografts. Transplantation 1997; 64: 448.
26. Pietra BA, Wiseman A, Bolwerk A, et al. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J Clin Invest 2000; 106: 1003.
27. Uchida T, Tomita Y, Anzai K, et al. Roles of CD4 and CD8 T cells in discordant skin xenograft rejection. Transplantation 1999; 68: 1721.
28. Krieger N, Ito H, Fathman C. Rat pancreatic islet and skin xenograft survival in CD4 and CD8 knockout mice. J Autoimmun 1997; 10: 309.
29. + T cells. J Immunol 1999; 162: 1206.
30. Nielsen B, Steinbruchel D, Lillevang S, et al. Evidence for a primarily humoral rejection mechanism in concordant xenogeneic heart transplantation: A sequential immunohistological study in a hamster-to-rat model. APMIS 1993; 101: 587.
31. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787.
32. Simeonovic C, Townsend M, Karupiah G, et al. Analysis of the Th1/Th2 paradigm in transplantation: Interferon-gamma deficiency converts Th1-type proislet allograft rejection to a Th2-type xenograft-like response. Cell Transplant 1999; 8: 365.
33. + T cell-mediated rejection of pancreatic islet allografts. J Immunol 2000;165: 247.